tiprankstipranks
Viking Therapeutics (VKTX)
NASDAQ:VKTX
Holding VKTX?
Track your performance easily

Viking Therapeutics (VKTX) Ownership - Who Owns Viking Therapeutics?

4,944 Followers

Viking Therapeutics (VKTX) Ownership Overview

2.71%26.66%16.56%14.08%40.00%
16.56% Other Institutional Investors
14.08% ETFs
40.00% Public Companies and Individual Investors
The ownership structure of Viking Therapeutics (VKTX) stock is a mix of institutional, retail, and individual investors. Approximately 57.30% of the company’s stock is owned by Institutional Investors, 2.71% is owned by Insiders, and 40.00% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 08, 2024
xxxxxxxxxxxxx
$137320
Jul 31, 2024
xxxxxxxxxxxxx
$922212
Jul 31, 2024
Brian Lian
President & Ceo,director
xxxxxxxxxxxxx
$6670604
Jul 31, 2024
xxxxxxxxxxxxx
$1029912

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$844175

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
9,581,104Institution8.60%470,528,017
9,118,405Institution8.18%447,804,870
6,288,618Institution5.64%308,834,030
2,933,076Institution2.63%144,043,362
2,304,927Insider2.07%113,194,965
1,958,186Institution1.76%96,166,514
1,797,566Institution1.61%88,278,466
1,699,987Institution1.53%83,486,362
1,248,793Institution1.12%61,328,224
753,487Institution0.68%37,003,747

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
9,118,405Institution8.18%447,804,870
6,288,618Institution5.64%308,834,030
1,958,186Institution1.76%96,166,514
1,248,793Institution1.12%61,328,224
753,487Institution0.68%37,003,747
550,408Institution0.49%27,030,537
499,779Institution0.45%24,544,147
376,515Institution0.34%18,490,652
373,563Institution0.34%18,345,679
350,731Institution0.31%17,224,399

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,322,559Institution2.98%210,351,210
2,634,893Institution2.36%166,815,076
2,878,239Institution2.58%142,703,090
1,657,144Institution1.49%104,913,787
1,452,921Institution1.30%91,984,429
589,142Institution0.53%28,932,764
536,754Institution0.48%26,612,263
329,799Institution0.30%20,879,575
375,782Institution0.34%18,454,654
344,213Institution0.31%16,904,300

FAQ

Who Owns Viking Therapeutics (VKTX)?
According to the latest TipRanks data, approximately 16.56% of the company's stock is held by institutional investors, 2.71% is held by insiders, and 40.00% is held by retail investors.
    What percentage of Viking Therapeutics (VKTX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 16.56% of Viking Therapeutics (VKTX) stock is held by institutional investors.
      What percentage of Viking Therapeutics (VKTX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 40.00% of Viking Therapeutics (VKTX) stock is held by retail investors.
        Who owns the most shares of Viking Therapeutics (VKTX)?
        Vanguard owns the most shares of Viking Therapeutics (VKTX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis